Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Humana reports first quarter 2023 results

2023 starts with good organic growth and profitabilitySummary of the first quarter · Net revenue was SEK 2,435 million (2,147), an increase of 13 percent.  · Organic growth was 5.5 percent (2.5) · Operating profit amounted to SEK 117m (77), an increase of 53 percent. Adjusted operating profit amounted to SEK 100m (77), an increase of 30 percent. · Net profit after tax for the period amounted to SEK 50m (29). · Earnings per share before and after dilution for the period amounted to SEK 1.04 (0.60). · Cash flow for the period amounted to SEK -120m (-123). Operating cash

Concentric AB transfer own shares

The participants in LTI 2020 have the right to receive 7,512 shares, and as the performance-based terms have been met; 7,512 shares will be transferred. In accordance with the terms of LTI 2020, 5,634 shares have a purchase price for the participants of SEK 126.20 and 1,878 shares have a purchase price of SEK 189.40. Under the authorisation from the annual general meeting 2023, the board of Concentric has resolved to sell a maximum of 7,512 shares on Nasdaq Stockholm. The difference between the sale price and the purchase price in the terms of LTI 2020 will be paid to the participants.

Interim report 1 January–31 March 2023

First QUARTER (1 January–31 March 2023) · Net sales for the quarter amounted to MSEK 107 (88). · Operating profit before depreciation and amortisation (EBITDA) totalled MSEK 76 (61). · Operating profit (EBIT) was MSEK 61 (46). · Profit after tax totalled MSEK 52 (37), corresponding to SEK 1.16 (0.90) per share. · Operating cash flow was MSEK 30 (67) and cash flow after investments amounted to MSEK -41 (47). · Production generated 87 GWh (100) of green electricity with an average income of SEK 936 per MWh (756). · In January 2023, Arise signed an agreement with Persson

SAGA: Notice to the Ordinary General Meeting

The Ordinary General Meeting in Saga Pure ASA will take place on 25 May 2023 at 13.00hrs (CET) as an electronic meeting. Information about participation and registration appears from the notice and its appendices and will be available on the Company's website www.sagapure.com. Further information about the electronic participation is enclosed to this message and will be published on the Company's website www.sagapure.com. Shareholders may submit their votes electronically in advance. Please see the instructions in the enclosed Notice. For additional information, please contact:

Eltel Group: Interim report January–March 2023

January–March 2023 · Net sales EUR 188.4 million (184.0). Total growth 2.4% and organic growth1) in segments 7.2% · Adjusted EBITDA EUR 2.4 million (5.1) · Adjusted EBITA2) EUR -5.5 million (-2.4) and adjusted EBITA margin -2.9% (-1.3) · Adjusted EBITA2) in segments EUR -2.1 million (0.7) and adjusted EBITA margin in segments -1.2% (0.4) · Items affecting comparability EUR -6.1 million (0.0) · Operating result (EBIT) EUR -11.6 million (-2.5) and EBIT margin -6.2% (-1.4) · Net result EUR -15.1 million (-4.4) · Earnings per share EUR -0.10 (-0.03), basic and diluted

Everysport Group (publ) publishes Interim Report for Q1 2023: Profitable core business, lower net sales due to reduced padel portfolio

Summary of the first quarter 2023: · Net sales SEK 43.5 million (50.3) · Adjusted EBITDA SEK 3.6 million (5.6) · EBITDA SEK 4.4 million (5.6) · Adjusted EBIT SEK -3.9 million (-5.6) · Profit after financial items SEK -7.6 million (-7.4) · Earnings per share -1.30 SEK (-1.10)“The business area Everysport Media reports a strong beginning of the year with increased net sales, positive EBIT and profit contribution. The strategically important B2C revenues increased by more than 20 percent as a result of once again breaking the record number of monthly subscribers in

Eurocine Vaccines receives grant from Merck Group

Eurocine Vaccines AB (publ) (“Eurocine Vaccines” or the “Company”) announces today that the Company has received a grant of SEK 300,000 from Merck Group (“Merck”).Merck regularly conducts and sponsors grant programs throughout different regions of the world to enable emerging biotech companies to meet the challenges they face in bringing the next generation drugs to market. Eurocine Vaccines was chosen based on their broad portfolio of vaccine candidates. Eurocine Vaccines will be able to use the SEK 300,000 towards Merck’s bioprocessing technologies and services to further expedite their

Cereno Scientific’s Phase II study in the rare disease PAH reports two patients successfully completed the treatment period with drug candidate CS1

Cereno Scientific (XSAT: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that two patients have successfully completed the treatment period in the study. The study is proceeding according to plan and top-line results are anticipated at year-end 2023.“We are happy to see further progress in the Phase II study with CS1; recruitment is still a major focus, however, equally important is that patients are able to successfully complete the study treatment period with CS1,” Björn Dahlöf, CMO at Cereno. “I am pleased with the

Relais Group Plc Interim Management Statement January-March 2023 (unaudited): Strong and profitable growth

Relais Group PlcStock Exchange Release 4 May 2023, 9.00 a.m. EEST This release is a summary of Relais Group's Interim Management Statement January-March 2023. The full release is attached to this release and is available on our website at https://relais.fi/en/investors/. Corporate acquisitions, implemented profitability and operative efficiency improvement measures as well as sales growth especially in the commercial vehicle maintenance and repair business improved profitability and cash flow from operations. JANUARY-MARCH 2023 IN BRIEF · Net sales totalled EUR 69.0 million (

Pavel Hajman appointed CEO of Husqvarna Group

In January 2023, the Board of Husqvarna Group announced that it would start a recruitment process to identify a new CEO, with Pavel continuing as interim CEO. That recruitment process is now completed, with the Board appointing Pavel Hajman to continue as Group CEO.Pavel has been acting CEO since December 2022, following a career of more than 30 years in leading positions within and outside Husqvarna Group. "We are delighted to announce the appointment of Pavel Hajman as the new CEO of the Husqvarna Group. It has been an extensive recruitment process and we strongly believe that Pavel

SaaS Platform, Teneo, and its Conversational IVR Solution, OpenQuestion, Now Available on Genesys AppFoundry.

Teneo.ai,  a brand from Artificial Solutions, announced today that its conversational platform Teneo  and its OpenQuestion  solution are now available on the Genesys AppFoundry™,  a marketplace of solutions offering a curated selection of applications and integrations that elevate customer and employee experiences.Teneo’s integration is now available with Genesys Cloud CX™, an all-in-one

Gaming Innovation Group reports Q1 2023

Gaming Innovation Group Inc. (GiG) reports Q1 2023 revenues* of €28.4 million and an adjusted EBITDA of €11.7 million.  “The first quarter of 2023 had a multitude of successful and impressive steps forward for Gaming Innovation Group. Many of which are contributing to create excitement within the business of further potential of the companies within the Group.”, says Richard Brown, CEO of GiG.  Financial Highlights · GiG achieved all-time high revenues* in Q1 2023 amounting to €28.4m (19.1), an increase of 49% YoY, whereof 19% organic    · Adjusted EBITDA was €11.7m (6.7), up

HC Andersen Capital Events 04/05: Meet the top management in Agillic & North Media

HC Andersen Capital is hosting digital events where you can meet and ask questions directly to the top management. It is free for all to attend.Agillic – Presentation of Q1 results 2023Agillic expects to report its Q1 results 2023 on 4 May 2023. The company’s management will present the financial results and update on the recent business highlights in a virtual live event later the same day at 14:00. The presentation will be followed by a Q&A session.  Looking at some of the latest news, Agillic has announced Viking Venture as a new investor and its largest individual shareholder,

ADDvise Group contemplates issuance of new senior secured bonds and redemption of its existing bonds

Further to recent communication, ADDvise Group AB (publ) (“ADDvise”) has mandated Pareto Securities AB and Skandinaviska Enskilda Banken AB (publ) to arrange a series of fixed income investor meetings starting on 8 May 2023. Subject to inter alia market conditions, a senior secured bond issue in an expected amount of SEK 1 billion and with a tenor of three years may follow (the “Bond Issue”). The proceeds from the Bond Issue will be used to refinance existing debt and to finance general corporate purposes including acquisitions. Accordingly, subject to a successful Bond Issue, ADDvise

HusCompagniet adjusts full-year financial guidance for 2023

Company announcement 9/2023HusCompagniet adjusts full-year 2023 outlook issued on 9 March 2023 and increases EBITDA before special items, due to enhanced visibility. We now expect an EBITDA before special items of DKK100-130 million. Adjusted outlook for 2023: · Revenue is expected to be DKK 2,250-2,500 million (previously DKK 2,200-2,500) · EBITDA before special items is expected to be DKK 100-130 million (previously DKK 75-125) · EBIT is expected to be DKK 50-75 million (previously DKK 25-75) EBIT guidance adjustment includes special items effect of DKK 5-10 million from

Interim report Q1: Profitable growth and strong cash conversion

January – March 2023 · Net sales increased with 44 % and amounted to SEK 912 (632) million · Organic growth increased with 21 (29) % · Adjusted EBIT increased with 56 % and amounted to SEK 34 (22) million with a margin of 3.7 (3.5) % · Cash flow from operating activities increased to SEK 93 (12) million · Earnings per share for the period before and after dilution increased to SEK 0.29 (0.19) "Nordisk Bergteknik delivered continued profitable growth during the first quarter of the year, which is seasonally our weakest as project activity is lower. Net sales increased

Hoist Finance interim report Q1 2023

“We have had a good start of the year with high investment levels, strong collection performance, intensive continued rejuvenation activities and a financial result showing that we are moving towards achieving our financial objectives” says Harry Vranjes, CEO. Key highlights · Profit before tax of SEK 162m adjusted for rejuvenation cost of SEK 18m, increased by 113 per cent compared to the first quarter 2022[1)] · Reported return on equity of 6 per cent. Adjusted for normalised capitalisation levels and rejuvenation costs the return on equity is approx 10 per cent[2)] ·

Atlas Copco has acquired an Italian compressed air distributor

Nacka, Sweden, May 4, 2023: Atlas Copco has acquired C.P. Service SRL, a compressor distributor and service provider located in Naples in the south of Italy.C.P. Service was founded in 1999 and has 13 employees. The company serves a wide range of industrial customers ranging from small to larger size, mainly in the Campania and Latium regions. The turnover in 2022 was approximately 6 MEUR (60 MSEK*). “The company has built up a strong customer base in the area,” said Vagner Rego, Business Area President Compressor Technique. “Through this acquisition we will increase our service and

Hufvudstaden welcomes ATP Atelier to Bibliotekstan

In the autumn of 2023, we will welcome Swedish shoe and accessory brand ATP Atelier to Jakobsbergsgatan 6 in Bibliotekstan, making the brand the latest tenant to move into Vildmannen 7, the soon-to-be rebuilt property on the corner of Biblioteksgatan and Jakobsbergsgatan.ATP Atelier is an international accessories brand that combines Scandi-cool and timeless design with traditional Italian craftsmanship. All footwear and bags are designed in Stockholm and handmade in Tuscany. The brand was founded in 2011 by Maj-La Pizzelli and Jonas Clason.   “It’s been just over 10 years since we

Musti Group plc Half-Year Financial Report 1 October 2022 – 31 March 2023

Musti Group plc                Half-Year Financial Report             4 May 2023 at 8:30 a.m. EEST Musti Group plc Half-Year Financial Report 1 October 2022 – 31 March 2023 Solid first half of the financial year January – March 2023    · Group net sales totaled EUR 101.7 (92.4) million, an increase of 10.0%. · Group net sales growth excluding the changes in the currency exchange rates was 15.4% · Like-for-like sales growth was 10.8%. · Adjusted EBITDA was EUR 16.6 (14.0) million, up by 19.3%. · Adjusted EBITDA margin was 16.4% (15.1%). · Adjusted EBITA was EUR 8.

Interim report January – March 2023

High organic growth and strengthened profitabilityJanuary – March 2023 · Net sales increased by 26.4 percent and amounted to SEK 3,264 (2,583) million. Organic growth, adjusted for currency effects, amounted to 12.5 (7.8) percent. · EBITA increased by 34.1 percent and amounted to SEK 233 (173) million. · The EBITA margin was 7.1 (6.7) percent. · Depreciation/amortisation of property, plant and equipment and intangible assets increased by SEK 40 million and amounted to SEK 112 (72) million. · Operating profit (EBIT) amounted to SEK 190 (151) million. · Cash flow from

Neogap and Cellerys enter collaboration related to Phase II study of a new therapy for multiple sclerosis

Neogap Therapeutics, a privately held biopharmaceutical company focusing on immuno-oncology based at the Centre for Molecular Medicine at Karolinska Institutet, Stockholm, Sweden, and Cellerys, a Zurich-based company researching an innovative therapy to fight multiple sclerosis (MS), have entered a collaboration.Cellerys will use Neogap’s patented EpiTCer[® ]technology in its upcoming Phase II study of a new type of cell therapy aimed at inducing antigen-specific immune tolerance in patients with multiple sclerosis (MS). Neogap EpiTCer[® ]technology will help detect rare autoreactive T

Interim report on Q1 2023 – Boosting our appeal

Despite an unsettled operating environment and a challenging macroeconomic situation, we are boosting our appeal. Our offering is consistent with our clients’ needs and interest in joining PE has never been greater. We are contributing to shareholder value by creating an efficient organisation with long-term profitable growth.First quarter, 1 January-31 March 2023 · Net revenue totalled SEK 245.8 million (250.3). · An agreement to settle a dispute relating to Soleed Sweden AB (wound up in 2016) affected revenue and EBITA for the quarter by SEK -5.2 million. · EBITA was SEK 12.7

There are no items matching the current filter
There are no more items matching the current filter
Back to top